Intravesical drug administration is used to deliver cytotoxic agents through a catheter to 
INTRODUCTION

30
Urinary bladder cancer and interstitial cystitis are widespread and serious urological bladder via a catheter (Malmstrom, 2003 , Gasion and Cruz, 2006 , Nirmal et al., 2012 , 35 Haupt et al., 2013 . This provides localized treatment, minimizes systemic side effects 36 and allows direct exposure of the affected tissue to therapeutic agents. However, 37 intravesical drug delivery also has some limitations. The normal capacity of the bladder 38 is 400-600 mL, but filling to 150-300 mL causes the urge to urinate. Due to periodical 39 voiding of urine from the bladder, instilled drug formulations can be rapidly washed out, 40 requiring frequent repeated administration (Guhasarkar and Banerjee, 2010) .
41
Additionally, frequent use of catheters is inconvenient for the patients and may cause 42 inflammatory reactions and infections.
43
The residence time of a dosage form in the bladder can potentially be improved by 44 using mucoadhesive materials, which could adhere to the epithelial mucosa and resist 45 drug washout. Mucoadhesive formulations for intravesical drug delivery must satisfy 46 three main criteria: they should adhere rapidly to the bladder mucosa, should not 3 interfere with the normal functions of the bladder and should be retained in situ even 48 after urination (Tyagi et al., 2006) .
49
Hydrophilic polymers are traditionally used as mucoadhesive materials in many 50 formulations for transmucosal drug delivery (Peppas, 1996; Andrews, 2009; 51 Khutoryanskiy, 2011) and commonly used are chitosan and carbomers (weakly cross-52 linked poly(acrylic acid). The adhesion of these polymers to mucosal surfaces is through 53 non-covalent interactions such as hydrogen bonding, electrostatic attraction, 54 hydrophobic effects and diffusion and interpenetration (Khutoryanskiy, 2011) . Recently, properties of polymers including the introduction of thiol groups 57 2004), acrylate groups (Davidovich-Pinhas, 2011) , catechols (Kim, 2015) and boronates 58 (Liu, 2015) .
59
The literature contains few reports on chemically modified and enhanced mucoadhesive 60 materials for intravesical drug delivery. Barthelmes et al (2011 Barthelmes et al ( , 2013 Storha et al (2013) developed thiolated nanoparticles using thiol-ene click chemistry and 64 studied their retention on porcine urinary bladder mucosa in vitro. Zhang et al (2014) 65 reported the synthesis of a series of β-cyclodextrin modified mesoporous silica 66 nanoparticles with hydroxyl, amino, and thiol groups. They demonstrated that retention 67 of thiol-functionalized nanoparticles on the urothelium was significantly higher than the 68 hydroxyl-and amino-functionalized materials.
69
Previously we have reported the synthesis of thiolated silica nanoparticles using self-70 condensation of (3-mercaptopropyl)trimethoxysilane in dimethylsulfoxide 71 (Irmukhametova, 2011; Irmukhametova 2012; Mun, 2014a) . These nanoparticles exhibited strong adhesion to ocular tissues and withstood repetitive washes with 73 artificial tear fluid (Irmukhametova, 2011; Mun, 2014b placed onto the mucosal surface, fluorescence microscopy images were again taken, 179 followed by 7 washing cycles, for each of which the bladder tissue was irrigated with 10 180 mL of artificial urine solution at 5 mL/min using a syringe pump. Fluorescence 181 microscopy images (3 for each sample) were recorded initially after treatment and after 182 each wash with the bladder tissue being placed onto a 75 mm x 25 mm glass slide. tissue prior to exposing it to the test material and the initial (pre-wash) fluorescence was 189 taken as an intensity of 1.
190
Since the wash off experiments were not carried out in total darkness, to exclude the Thiolated silica nanoparticles were synthesized using self-condensation of (3- still numerous thiol-groups available for mucoadhesion and for further functionalization.
231
The fluorescently labelled nanoparticles were characterized using dynamic light 232 scattering, fluorescent spectroscopy and Ellman's assay. Figure 1 shows size 233 distributions of the nanoparticles formed in DMSO, DMF and AcN, determined using 234 dynamic light scattering, illustrating the influence of changing solvent polarity on particle 235 size, but with similar dispersities.
236
Previously (Irmukhametova et al, 2011) it was demonstrated that PEGylation prevents 237 the adhesion of thiolated silica to intact bovine cornea, but could facilitate their 238 penetration into more porous stroma in de-epithelialized cornea (Mun et al, 2014 As expected, PEGylation generated larger nanoparticle size distributions, similar to our 250 previous findings (Mun, 2014b showing that the greater the molecular weight of PEG shell, the larger the nanoparticles.
253
PEGylation also reduced thiol groups content from 249±30 µmol/g to 95±6 µmol/g and 254 78±5 µmol/g, when the nanoparticles were decorated with 750 Da and 5000 Da PEG,
255
respectively. Additionally, due to the screening effect of the PEG shells, reduced 
277
The retention of fluorescently-labelled thiolated and PEGylated silica nanoparticles on 278 porcine urinary bladder mucosa was studied using a flow-through method with 279 fluorescent detection (Irmukhametova, 2011; Storha, 2013; Withers, 2013) . surfaces (Sogias et al., 2008 , Khutoryanskiy, 2011 . Fluorescently-labelled dextran, on 285 the contrary, had very poor adhesion to mucosal surfaces (Storha, 2013; Withers, 286 2013), and so was used as a negative control in our experiments.
287
Analysis of the fluorescent images using ImageJ software allows the retention of 288 fluorescent species on mucosal surfaces to be quantified (Figure 3) . FITC-chitosan is 289 retained on the bladder surface even after 7 washes (total volume 70 mL) with artificial 290 urine solution and illustrates its strong interaction with the mucosal surface. However,
291
for FITC-dextran, a significant decrease in fluorescence was observed after the first 292 wash (10 mL) with urine solution, confirming its poor mucoadhesive properties. hydrogen bonding) with mucins and generate an interpenetration layer (Sogias, 2008) .
303
This interpenetration could potentially facilitate better retention of chitosan on the 304 bladder mucosa compared to thiolated nanoparticles.
305
PEGylated silica nanoparticles were washed from the mucosal surface more rapidly (Table 1) .
316
The poorer mucoadhesive performance of PEGylated nanoparticles compared to the 317 thiolated silica is in good agreement with our previous study of retention of similar 318 nanoparticles on the ocular surfaces (Irmukhametova, 2011 of two mucosal tissues (Irmukhametova et al., 2011) ; the rougher structure of the 325 bladder epithelium compared to the cornea provides better retention of silica 326 nanoparticles on its mucosal surface.
327
Retention studies were conducted with differing sizes of thiolated silica nanoparticles, 328 synthesized in different aprotic solvents (DMSO, DMF and AcN, Table 1 ). Figure 4 329 shows the retention profiles for these nanoparticles. The greatest retention in this series is observed for 21±1 nm thiolated nanoparticles, 
